PixCell HemoScreen Analyzer
In Stock! Ready for Immediate Shipment!
*Please click RFQ if you are interested in receiving additional information and pricing information
*Currently: CLIA Classified for Moderately Complex/ Certificate of Accredited Labs Only
The only FDA Cleared POC Hematology Instrument
HemoScreen™ harnesses PixCell Medical's AI-assisted Viscoelastic Focusing (VEF) technology to perform lab-grade analysis on a single blood drop sample, as it passes through a unique lab-on-a-cartridge. It is extremely simple to operate, requires no maintenance or calibration, and is fully portable.
The HemoScreen platform can perform highly complex blood tests, currently confined to high-end labs, in a simple, portable POC instrument.
Making such blood tests extremely accessible will enable early detection of the most critical health issues, and thus save lives.
HemoScreen in the News
CLIAwaived is thrilled to announce a groundbreaking development that takes HemoScreen, a state-of-the-art 5-part differential CBC analyzer, to a new level of convenience, efficiency, and accessibility.
The recent FDA clearance for direct capillary sampling has unlocked more potential for HemoScreen as a true point-of-care hematology solution. This achievement marks a significant milestone in the world of medical diagnostics, empowering healthcare professionals with an unparalleled tool for quick, accurate, and hassle-free blood analysis. The true essence of this innovation lies in the seamless direct capillary blood collection technique, which simplifies the sampling process and minimizes pre-analytical errors. Unlike conventional methods involving tubes and multiple transfers, HemoScreen's direct capillary sampling eliminates complexity, reduces the risk of clotting and contamination, and requires minimal expertise.
Read about HemoScreen's unparalleled direct sampling benefits
